Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722239 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket



Investment Report of China Medical Industry, 2000-2008 (Chinese Version)
Research In China, July 2008, Pages: 126


  Description  
  Table of Contents  
  Companies Mentioned  
    
    
   
 Enquire before Buying  
 Send to a Friend  

China is the largest country in the world in terms of population. Its population of 1.3 billion people provides a huge market for the development of China's medical service industry. The existing medical resources are far from being able to satisfy people's demand, which results in the problems to be difficult and expensive to see a doctor. However, China's non-public medical service industry is underdeveloped seriously. So China has put forward the ideas to develop medical and health service system by actively introducing non-public funds, which provides a great opportunity for the development of China's non-public medical service industry.

From Jan. to Nov. 2007, the total industrial output value of China's medical instrument and apparatus manufacturing industry hit CNY51.446 billion, up 21.42% against the same period of the previous year, while the accumulated sales revenue and accumulated profit reached CNY49.32 billion and CNY5.26 billion, up 22.17% and 42.51% year on year respectively. In the next few years, China will surpass Japan and become the second largest medical instrument market in the world. The total output value of China's medical instruments and apparatus industry will reach CNY100 billion in 2010, taking up 5% share in the world's medical instruments and apparatus market.

This report makes an in-depth analysis on all investment projects financed by 18 listed companies, covering medical apparatus producers, medical service providers and pharmaceutical producers with investment in medical instruments, from 2000 to 2008 and also makes summary of investment trends of China's medical industry as well as investment features and investment trends of the listed companies.

Among the 18 listed companies, Shanghai Pharmaceutical Co. Ltd. ranks first in terms of investment amount from the year of 2000 to the first half of 2008 with a total amount of CNY2.55 billion, followed by Wuhan Humanwell Hi-tech Industry Co., Ltd. and Chengzhi Shareholding Co., Ltd.

This report makes an in-depth analysis on all investment projects financed by the 18 listed companies. For example, Shanghai Pharmaceutical Co., Ltd. (600849) is referred in this report.

Investment Features of Shanghai Pharmaceutical Co., Ltd

Main Business: production, distribution and retail of traditional Chinese medicine and western medicine; diversification direction: pharmaceutical logistics industry.

The company has kept a high investment amount for many years. Its investment hit CNY625 million in 2004, which is the highest record of this company. In the past four years, its investment was mainly financed by non fund raising. Its investment is concentrated in East China.

The company is one of the three giants in China's pharmaceutical distribution industry. Medicine distribution is its highlight, covering more than 3,900 hospitals across China with sales of more than CNY9 billion. With the help of its strategy of international development, the company together with SUZUKEN Co., Ltd., a world leader in pharmaceutical distribution, has set up a joint venture engaged in pharmaceutical distribution. It has also signed OEM agreement with American Perrigo Company (NASDAQ: PRGO) regarding seven varieties of products and the commitment of 2.1 billion pieces a year, which is hopeful to reach three billion pieces annually. As for pharmaceutical logistics, the company has built a logistics center with an annual throughput of CNY15 billion.

Note: When you purchase this report, we can update the data to the most recent quarter.


This title is also available in the following language

Investment Report of China Medical Industry, 2000-2008 (English Version)



Customers who bought this item also bought

Investment Report of China Medical Industry, 2000-2008

Investment Report of China Retail Industry, 2000-2008

Investment Report of China Retail Industry, 2000-2008

Investment Report of China Steel Industry, 2000-2008

Investment Report of China Steel Industry, 2000-2008

Investment Report of China Listed Catering and Tourism Companies, 2000-2008

Investment Report of China Listed Catering and Tourism Companies, 2000-2008

Investment Report of China Coal Industry, 2000-2008

Investment Report of China Coal Industry, 2000-2008

Investment Report of China Transport Infrastructure Industry, 2000-2008

Investment Report of China Transport Infrastructure Industry, 2000-2008

Investment Report of China Financial Service Industry, 2000-2008



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds